How Somatostatin Interacts with Hexarelin's Growth Hormone-Releasing Effect in Humans
Changing somatostatin tone significantly affects hexarelin's GH-releasing effect, and somatostatin withdrawal can trigger a rebound GH release that hexarelin amplifies.
Quick Facts
What This Study Found
Hexarelin's GH-releasing effect is significantly modulated by somatostatin tone, with somatostatin withdrawal amplifying the GH response to hexarelin.
Key Numbers
How They Did This
Clinical trial testing hexarelin GH response during various somatostatin states (high tone, low tone, withdrawal) in human subjects.
Why This Research Matters
Understanding the hexarelin-somatostatin interaction explains why GHRPs work best at certain times and informs optimal dosing strategies.
The Bigger Picture
This study helped establish the clinical principle that GHRP timing matters — the somatostatin fluctuation cycle creates windows of enhanced responsiveness.
What This Study Doesn't Tell Us
Clinical trial with artificial somatostatin manipulation. Natural somatostatin fluctuations may produce different interactions.
Questions This Raises
- ?Can GHRP dosing be timed to natural somatostatin troughs for maximum effect?
- ?Does chronic GHRP use alter the somatostatin cycle?
Trust & Context
- Key Stat:
- Timing matters for GHRPs Somatostatin withdrawal creates a window where hexarelin's GH-releasing effect is amplified
- Evidence Grade:
- Strong clinical evidence from a controlled human study manipulating somatostatin states.
- Study Age:
- Published in 1997, informing current GHRP dosing timing recommendations.
- Original Title:
- Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
- Published In:
- Clinical endocrinology, 47(5), 537-47 (1997)
- Authors:
- Massoud, A F(2), Hindmarsh, P C(2), Brook, C G(2)
- Database ID:
- RPEP-00417
Evidence Hierarchy
Frequently Asked Questions
When is the best time to take hexarelin?
This study shows hexarelin works best when somatostatin is low. Natural somatostatin troughs occur during fasting and in the early part of sleep, which is why GHRPs are typically taken on an empty stomach or at bedtime.
What is somatostatin withdrawal?
When somatostatin levels drop after being elevated, the pituitary becomes temporarily more responsive to GH-releasing signals — a rebound effect. Hexarelin given during this window produces an amplified GH release.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00417APA
Massoud, A F; Hindmarsh, P C; Brook, C G. (1997). Interaction of the growth hormone releasing peptide hexarelin with somatostatin.. Clinical endocrinology, 47(5), 537-47.
MLA
Massoud, A F, et al. "Interaction of the growth hormone releasing peptide hexarelin with somatostatin.." Clinical endocrinology, 1997.
RethinkPeptides
RethinkPeptides Research Database. "Interaction of the growth hormone releasing peptide hexareli..." RPEP-00417. Retrieved from https://rethinkpeptides.com/research/massoud-1997-interaction-of-the-growth
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.